Piper Sandler Maintains Overweight on Alpha Tau Medical, Lowers Price Target to $8
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Jason Bednar has maintained an Overweight rating on Alpha Tau Medical (NASDAQ:DRTS) but reduced the price target from $12 to $8.
November 17, 2023 | 5:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Piper Sandler has maintained an Overweight rating on Alpha Tau Medical but lowered the price target from $12 to $8, indicating a potential downside compared to the previous target.
The reduction in price target by Piper Sandler, despite maintaining an Overweight rating, suggests that they see less upside potential for Alpha Tau Medical's stock price in the short term. This could lead to a negative investor sentiment and a potential decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100